NO20071774L - Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av generalisert angstlidelse - Google Patents

Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av generalisert angstlidelse

Info

Publication number
NO20071774L
NO20071774L NO20071774A NO20071774A NO20071774L NO 20071774 L NO20071774 L NO 20071774L NO 20071774 A NO20071774 A NO 20071774A NO 20071774 A NO20071774 A NO 20071774A NO 20071774 L NO20071774 L NO 20071774L
Authority
NO
Norway
Prior art keywords
treatment
agomelatin
disorders
taking medications
medications intended
Prior art date
Application number
NO20071774A
Other languages
English (en)
Norwegian (no)
Inventor
Mark Millan
Elisabeth Mocaer
Bruno Delalleau
Agnes Fabiano
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20071774(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20071774L publication Critical patent/NO20071774L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20071774A 2006-04-07 2007-04-03 Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av generalisert angstlidelse NO20071774L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603083A FR2899472B1 (fr) 2006-04-07 2006-04-07 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee

Publications (1)

Publication Number Publication Date
NO20071774L true NO20071774L (no) 2007-10-08

Family

ID=37308935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071774A NO20071774L (no) 2006-04-07 2007-04-03 Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av generalisert angstlidelse

Country Status (44)

Country Link
US (1) US7960438B2 (pt)
EP (1) EP1842535B1 (pt)
JP (1) JP4880031B2 (pt)
KR (1) KR20070100657A (pt)
CN (1) CN101049290B (pt)
AP (1) AP2488A (pt)
AR (1) AR060349A1 (pt)
AT (1) ATE477798T1 (pt)
AU (1) AU2007201527B2 (pt)
BR (1) BRPI0701601A (pt)
CA (1) CA2584060C (pt)
CO (1) CO5840252A1 (pt)
CR (1) CR9019A (pt)
CY (1) CY1111287T1 (pt)
DE (1) DE602007008494D1 (pt)
DK (1) DK1842535T3 (pt)
EA (1) EA012608B1 (pt)
ES (1) ES2351062T3 (pt)
FR (1) FR2899472B1 (pt)
GE (1) GEP20094743B (pt)
GT (1) GT200700032A (pt)
HK (1) HK1108367A1 (pt)
HR (1) HRP20100577T1 (pt)
IL (1) IL182407A (pt)
JO (1) JO3440B1 (pt)
MA (1) MA28987B1 (pt)
ME (1) ME01865B (pt)
MX (1) MX2007004100A (pt)
MY (1) MY143269A (pt)
NI (1) NI200700084A (pt)
NO (1) NO20071774L (pt)
NZ (1) NZ554347A (pt)
PE (1) PE20080174A1 (pt)
PL (1) PL1842535T3 (pt)
PT (1) PT1842535E (pt)
RS (1) RS51485B (pt)
SA (1) SA07280161B1 (pt)
SG (1) SG136881A1 (pt)
SI (1) SI1842535T1 (pt)
TN (1) TNSN07118A1 (pt)
TW (1) TWI374736B (pt)
UY (1) UY30262A1 (pt)
WO (1) WO2007116136A1 (pt)
ZA (1) ZA200702865B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN101585779B (zh) * 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用
FR2956031B1 (fr) * 2010-02-11 2012-03-02 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble obsessionnel compulsif (toc)
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
PH12012000132A1 (en) * 2011-06-09 2014-10-20 Servier Lab New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
HUE036989T2 (hu) 2013-06-06 2018-08-28 Zentiva Ks Agomelatin készítmény, amely agomelatint ko-kristály formájában tartalmaz
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
CN110867197A (zh) * 2019-10-23 2020-03-06 吴杰 语音交互过程中实时打断语音机器人的方法及设备

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
SG45100A1 (en) * 1994-03-07 1998-01-16 Ibm Improvements in image processing
DE19532842C1 (de) * 1995-09-05 1996-12-19 Ibm Bildaufnahmesystem
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
US20050164987A1 (en) * 2003-12-24 2005-07-28 Barberich Timothy J. Melatonin combination therapy for improving sleep quality
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions

Also Published As

Publication number Publication date
ATE477798T1 (de) 2010-09-15
ME01865B (me) 2011-04-30
AP2488A (en) 2012-10-03
CA2584060C (fr) 2011-04-26
EP1842535A1 (fr) 2007-10-10
SI1842535T1 (sl) 2010-10-29
CO5840252A1 (es) 2007-12-31
HRP20100577T1 (hr) 2010-11-30
AR060349A1 (es) 2008-06-11
AP2007003953A0 (en) 2007-04-30
MX2007004100A (es) 2009-02-16
TWI374736B (en) 2012-10-21
CY1111287T1 (el) 2015-08-05
HK1108367A1 (en) 2008-05-09
PL1842535T3 (pl) 2011-01-31
FR2899472A1 (fr) 2007-10-12
KR20070100657A (ko) 2007-10-11
CR9019A (es) 2008-10-28
BRPI0701601A (pt) 2007-12-11
EA200700574A3 (ru) 2007-12-28
MA28987B1 (fr) 2007-11-01
AU2007201527A1 (en) 2007-10-25
SG136881A1 (en) 2007-11-29
PE20080174A1 (es) 2008-03-29
ZA200702865B (en) 2008-07-30
CA2584060A1 (fr) 2007-10-07
CN101049290A (zh) 2007-10-10
DK1842535T3 (da) 2010-11-15
ES2351062T3 (es) 2011-01-31
TNSN07118A1 (fr) 2008-06-02
WO2007116136A1 (fr) 2007-10-18
JP4880031B2 (ja) 2012-02-22
SA07280161B1 (ar) 2010-10-23
FR2899472B1 (fr) 2008-09-12
PT1842535E (pt) 2010-09-28
MY143269A (en) 2011-04-15
IL182407A0 (en) 2008-01-20
AU2007201527B2 (en) 2012-08-09
US20070238792A1 (en) 2007-10-11
EA200700574A2 (ru) 2007-10-26
JO3440B1 (ar) 2019-10-20
GEP20094743B (en) 2009-07-27
UY30262A1 (es) 2007-05-31
NI200700084A (es) 2008-04-24
IL182407A (en) 2016-02-29
TW200808295A (en) 2008-02-16
CN101049290B (zh) 2012-10-31
DE602007008494D1 (de) 2010-09-30
EA012608B1 (ru) 2009-10-30
EP1842535B1 (fr) 2010-08-18
NZ554347A (en) 2008-08-29
JP2009532446A (ja) 2009-09-10
US7960438B2 (en) 2011-06-14
GT200700032A (es) 2007-10-31
RS51485B (en) 2011-04-30

Similar Documents

Publication Publication Date Title
NO20071774L (no) Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av generalisert angstlidelse
NO20064050L (no) Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av sovnforstyrrelser i den deprimerte pasient
NO20075989L (no) Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av Smith-Magenis syndrom
UY29470A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos bipolares
EA201201123A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения обсессивно-компульсивного расстройства (окр)
NO20076002L (no) Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av periventrikulaer levkomalasi
CU20070070A7 (es) Composición farmacéutica de agomelatina
UA88322C2 (ru) Применение агомелатина как единственного активного агента в получении лекарственных средств, предназначенных для лечения генерализованного тревожного расстройства
CU20070232A7 (es) Utilización de la agomelatina para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares
NO20064049L (no) Ny assosiasjon mellom agomelatin og et tymoregulerende middel og farmasoytiske sammensetninger inneholdende den

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application